Antibodies

Items 51-56 of 56

Page
per page
Set Descending Direction
  1. anti-Phospho-Histone H4 (Ser1), Rabbit Monoclonal (RM194)
    REV-31-1079-00
    REV-31-1079-00-C02525 µg
    CHF 251.00
    REV-31-1079-00-C100100 µg
    CHF 559.00
    Immunocytochemistry of HeLa cells, using Anti-Phospho-Histone H4 (Ser1) Rabbit mAb RM194 (red). Actin filaments have been labeled with fluorescein phalloidin (green).
  2. anti-Phosphothreonine, Rabbit Monoclonal (RM102)
    REV-31-1009-00
    REV-31-1009-00-C100100 µg
    CHF 518.00
    Immunocytochemistry of serum-starved A431 cells nontreated or treated with Calyculin A/ Okadaic Acid, using RevMAb Clone RM102 at 1/500 dilution (followed by PE conjugated secondary antibody, red) and DAPI (blue).
  3. anti-Polyglutamate chain (polyE), pAb (IN105)
    AG-25B-0030
    AG-25B-0030-C05050 µg
    CHF 460.00
    Western blot analysis of protein polyglutamylation by anti-Polyglutamate chain (polyE), pAb (IN105) (Prod. No. AG-25B-0030).Method: HEK-293T cells are grown in standard culture conditions, transfected with plasmids expressing the tubulin glut
  4. anti-Polyglutamylation Modification, mAb (GT335)
    AG-20B-0020
    AG-20B-0020-C100100 µg
    CHF 495.00
    Western blot analysis of protein glutamylation with MAb to polyglutamylation modification (GT335) (Prod. No. AG-20B-0020).
Method: HeLa cells grown in standard culture conditions are lysed in SDS sample buffer and run on 10% SDS-PAGE. The pro
  5. anti-Polyglutamylation Modification, mAb (GT335) (Biotin)
    AG-20B-0020B
    AG-20B-0020B-C100100 µg
    CHF 530.00
  6. anti-Tubulin (glycylated), pAb (Gly-pep1)
    AG-25B-0034
    AG-25B-0034-C100100 µg
    CHF 440.00
    Immunoblot analysis of protein glycylation using anti-Tubulin (glycylated), pAb (Gly-pep1) (Prod. No. AG-25B-0034). Method: HEK-293T cells are grown in standard culture conditions, transfected with plasmids expressing the glycylases TTLL3 and TTLL8

Items 51-56 of 56

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.